The Mayo Alzheimer's Disease Center (ADC) was funded in 1990 as an Alzheimer's Disease Core Center. As such, it initially had the four required cores; Administrative, Clinical and Research Support, neuropathology, and Research Training and Information Transfer. It has subsequently added two satellite projects. The major scientific themes of the Center involve the epidemiology of Alzheimer's disease (AD) and the clinical, imaging and neuropathological evaluation of the boundary between normal aging and early AD. The administrative structure for the Center has dealt with the pilot project review process, the External Advisory Committee, and budgetary and personnel issues. The Clinical Core has developed a standardized mechanism for recruiting, evaluating and triaging patients from community and referral sources. The Neuropathology Core has provided neuropathologic diagnoses on cases of AD and normal controls and has processed and distributed biological tissue to other investigators. The Information Transfer Core has been active in promoting educational activities for professionals, paraprofessionals, patients and caregivers. A satellite in Jacksonville, Florida has been successful at recruiting minority and indigent patients as well as developing an autopsy program. A unique satellite project involving the clinical and laboratory evaluation of patients with neurodegenerative diseases an normal controls from Guam is progressing. In the proposed grant period we plan to continue with the four basic cores with minor modifications in their scope and function. We will also continue the satellite in Jacksonville, Florida. The satellite involving the patients and controls from Guam was designed only for the years 03-05 of the initial grant period and will be discontinued. We have proposed the addition of a Neuroimaging Core in this application to develop new techniques in magnetic resonance imaging to further the scientific themes of the ADC. The Mayo ADC has been productive in its initial years and this proposal represents its plan for continued growth in promoting research in AD.
| Jack Jr, C R; O'Brien, P C; Rettman, D W et al. (2001) FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging 14:668-76 |
| Jack Jr, C R; Petersen, R C; Xu, Y et al. (2000) Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55:484-89 |
| Jack Jr, C R; Petersen, R C; Xu, Y C et al. (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52:1397-403 |
| Leibson, C; Owens, T; O'Brien, P et al. (1999) Use of physician and acute care services by persons with and without Alzheimer's disease: a population-based comparison. J Am Geriatr Soc 47:864-9 |
| Jack Jr, C R; Petersen, R C; Xu, Y et al. (1998) Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 51:993-9 |
| Lucas, J A; Ivnik, R J; Smith, G E et al. (1998) Mayo's older Americans normative studies: category fluency norms. J Clin Exp Neuropsychol 20:194-200 |
| Lucas, J A; Ivnik, R J; Smith, G E et al. (1998) Normative data for the Mattis Dementia Rating Scale. J Clin Exp Neuropsychol 20:536-47 |
| Petersen, R C (1998) Clinical subtypes of Alzheimer's disease. Dement Geriatr Cogn Disord 9 Suppl 3:16-24 |
| Jack Jr, C R; Petersen, R C; Xu, Y C et al. (1998) Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol 43:303-10 |
| Ivnik, R J; Smith, G E; Lucas, J A et al. (1997) Free and cued selective reminding test: MOANS norms. J Clin Exp Neuropsychol 19:676-91 |
Showing the most recent 10 out of 22 publications
